Heidelberg Pharma AG (ETR:HPHA)
2.580
-0.020 (-0.77%)
Jun 19, 2026, 11:06 PM CET
Heidelberg Pharma AG Employees
Heidelberg Pharma AG had 60 employees as of February 28, 2026. The number of employees decreased by 45 or -42.86% compared to the same quarter last year.
Employees
60
Change
-45
Growth
-42.86%
Revenue / Employee
€53,647
Profits / Employee
€676,984
Market Cap
120.70M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Feb 28, 2026 | 60 | -45 | -42.86% |
| Nov 30, 2025 | 111 | 6 | 5.71% |
| Aug 31, 2025 | 114 | 9 | 8.57% |
| May 31, 2025 | 111 | 13 | 13.27% |
| Feb 28, 2025 | 105 | 7 | 7.14% |
| Nov 30, 2024 | 105 | 10 | 10.53% |
| Feb 29, 2024 | 98 | -2 | -2.00% |
| Nov 30, 2023 | 95 | -7 | -6.86% |
| Feb 28, 2023 | 100 | 11 | 12.36% |
| Nov 30, 2022 | 102 | 13 | 14.61% |
| May 31, 2022 | 93 | 6 | 6.90% |
| Feb 28, 2022 | 89 | 7 | 8.54% |
| Nov 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| May 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Feb 28, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Nov 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| May 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Feb 29, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Nov 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| May 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Feb 28, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Nov 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| May 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Feb 28, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Nov 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Feb 28, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Fresenius SE & Co. KGaA | 177,783 |
| Bayer Aktiengesellschaft | 87,757 |
| Siemens Healthineers AG | 73,800 |
| Merck KGaA | 59,077 |
| MEDICLIN Aktiengesellschaft | 7,416 |
| Stratec SE | 1,395 |
| FamiCord AG | 723 |
| DocCheck AG | 414 |
Heidelberg Pharma AG News
- 7 weeks ago - EQS-News: Heidelberg Pharma AG: Interim Statement on the First Three Months of Financial Year 2026 - Wallstreet:Online
- 7 weeks ago - Heidelberg Pharma AG Earnings release: Q1 2026 - Filings
- 2 months ago - EQS-Adhoc: Heidelberg Pharma AG: Heidelberg Pharma Determines Recommended Dose for Phase II Trial with ADC Candidate HDP-101 - Wallstreet:Online
- 3 months ago - Heidelberg Pharma AG Earnings Call Transcript: Q4 2025 - Transcripts
- 3 months ago - Heidelberg Pharma AG Annual report: Q4 2025 - Filings
- 3 months ago - Heidelberg Pharma AG Earnings release: Q4 2025 - Filings
- 3 months ago - Heidelberg Pharma AG Slides: Q4 2025 - Filings
- 3 months ago - Heidelberg Pharma AG Annual report: Q4 2025 - Filings